3D-QSAR studies on fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors by CoMFA and CoMSIA
- PMID: 17618469
- DOI: 10.1007/s00894-007-0221-8
3D-QSAR studies on fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors by CoMFA and CoMSIA
Abstract
Three-dimensional quantitative structure-activity relationship (3D-QSAR) analyses using CoMFA and CoMSIA methods were conducted on a series of fluoropyrrolidine amides as dipeptidyl peptidase IV (DP-IV) inhibitors. The selected ligands were docked into the binding site of the 3D model of DP-IV using the GOLD software, and the possible interaction models between DP-IV and the inhibitors were obtained. Based on the binding conformations of these fluoropyrrolidine amides and their alignment inside the binding pocket of DP-IV, predictive 3D-QSAR models were established by CoMFA and CoMSIA analyses, which had conventional r2 and cross-validated coefficient values ([Formula: see text]) up to 0.982 and 0.555 for CoMFA and 0.953 and 0.613 for CoMSIA, respectively. The predictive ability of these models was validated by six compounds that were in the testing set. Structure-based investigations and the final 3D-QSAR results provide the guide for designing new potent inhibitors.
Similar articles
-
3D-QSAR studies on triazolopiperazine amide inhibitors of dipeptidyl peptidase-IV as anti-diabetic agents.SAR QSAR Environ Res. 2009 Jul;20(5-6):519-35. doi: 10.1080/10629360903278677. SAR QSAR Environ Res. 2009. PMID: 19916112
-
Molecular docking and 3D-QSAR studies on beta-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors.J Mol Model. 2010 Jul;16(7):1239-49. doi: 10.1007/s00894-009-0637-4. Epub 2010 Jan 13. J Mol Model. 2010. PMID: 20069322
-
Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.Bioorg Med Chem. 2005 Sep 15;13(18):5424-34. doi: 10.1016/j.bmc.2005.05.016. Bioorg Med Chem. 2005. PMID: 15963726
-
3D-QSAR CoMFA, CoMSIA studies on substituted ureas as Raf-1 kinase inhibitors and its confirmation with structure-based studies.Bioorg Med Chem. 2004 Dec 15;12(24):6415-25. doi: 10.1016/j.bmc.2004.09.029. Bioorg Med Chem. 2004. PMID: 15556759
-
How to generate reliable and predictive CoMFA models.Curr Med Chem. 2011;18(6):923-30. doi: 10.2174/092986711794927702. Curr Med Chem. 2011. PMID: 21182474 Review.
Cited by
-
Identification of diverse dipeptidyl peptidase IV inhibitors via structure-based virtual screening.J Mol Model. 2012 Sep;18(9):4033-42. doi: 10.1007/s00894-012-1394-3. Epub 2012 Mar 30. J Mol Model. 2012. PMID: 22460522
-
Refinement and 3D-QSAR Studies of Inhibitors of Cyclophilin A Containing Amide Linker.QSAR Comb Sci. 2009 Feb;28(2):183-193. doi: 10.1002/qsar.200860076. Epub 2008 Nov 28. QSAR Comb Sci. 2009. PMID: 32327951 Free PMC article.
-
Covalent complexes of proteasome model with peptide aldehyde inhibitors MG132 and MG101: docking and molecular dynamics study.J Mol Model. 2009 Dec;15(12):1481-90. doi: 10.1007/s00894-009-0515-0. Epub 2009 May 14. J Mol Model. 2009. PMID: 19440739
-
In silico screening for identification of pyrrolidine derivatives dipeptidyl peptidase-IV inhibitors using COMFA, CoMSIA, HQSAR and docking studies.In Silico Pharmacol. 2017 Oct 23;5:13. doi: 10.1007/s40203-017-0032-2. eCollection 2017. In Silico Pharmacol. 2017. PMID: 29098139 Free PMC article.
-
Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses.BMC Cancer. 2022 Jun 22;22(1):687. doi: 10.1186/s12885-022-09763-2. BMC Cancer. 2022. PMID: 35733175 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources